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Abstract Complement factor C5a is one of the most
powerful pro-inflammatory agents involved in recruitment
of leukocytes, activation of phagocytes and other inflam-
matory responses. C5a triggers inflammatory responses by
binding to its G-protein-coupled C5a-receptor (C5aR).
Excessive or erroneous activation of the C5aR has been
implicated in numerous inflammatory diseases. The C5aR
is therefore a key target in the development of specific anti-
inflammatory compounds. A very potent natural inhibitor
of the C5aR is the 121-residue chemotaxis inhibitory pro-
tein of Staphylococcus aureus (CHIPS). Although CHIPS
effectively blocks C5aR activation by binding tightly to its
extra-cellular N terminus, it is not suitable as a potential
anti-inflammatory drug due to its immunogenic properties.
As a first step in the development of an improved CHIPS
mimic, we designed and synthesized a substantially shorter
50-residue adapted peptide, designated CHOPS. This
peptide included all residues important for receptor binding
as based on the recent structure of CHIPS in complex with
the C5aR N terminus. Using isothermal titration calorim-
etry we demonstrate that CHOPS has micromolar affinity
for a model peptide comprising residues 7–28 of the C5aR
N terminus including two O-sulfated tyrosine residues at
positions 11 and 14. CD and NMR spectroscopy showed
that CHOPS is unstructured free in solution. Upon addition
of the doubly sulfated model peptide, however, the NMR
and CD spectra reveal the formation of structural elements
in CHOPS reminiscent of native CHIPS.
Keywords C5a receptor  CHIPS  Inflammation 
Anaphylatoxin
Introduction
As part of the host defense system, the human complement
cascade initiates inflammatory responses directed against
invading infectious microorganisms, injury and other
threatening conditions (Lee et al. 2008). Complement
factor C5a is the most powerful pro-inflammatory agent
generated during complement activation. C5a interacts
with the membrane associated G-protein-coupled C5a
receptor (C5aR) resulting in chemotaxis of specific white
blood cells, activation of phagocytes, release of granule-
based enzymes, and the generation of oxidants (Guo and
Ward 2005). C5a is a 74-residue glycoprotein comprising a
bundle of four anti-parallel a-helices stabilized by three
disulfide bonds (PDB ID code: 1KJS). Binding and acti-
vation of the C5aR by C5a is considered a two-step pro-
cess, in which residues in the region between 12 and 46
of C5a bind to a primary binding site located in the
extra-cellular N terminus of the C5aR. Subsequently
the C-terminal portion of C5a (residues 69–74) binds to the
C5aR activation domain located inside the receptor core
(Chen et al. 1998; Gerber et al. 2001). Together these two
binding sites provide the complex of C5a and the C5aR
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sub-nanomolar affinity (Kd & 0.60 nM; van Epps et al.
1993). Although under normal circumstances C5a-medi-
ated C5aR activation is highly favorable, excessive levels
of C5a can be deleterious to the host and have been related
to numerous inflammatory and autoimmune diseases (e.g.
rheumatoid arthritis, inflammatory bowel disease and
reperfusion injury). Specific inhibition of C5aR activation
is considered a promising strategy to treat such conditions
(Allegretti et al. 2005). So far, the design and development
of novel anti-inflammatory agents was primarily focussed
on small organic compounds and short C5a peptide ana-
logs, which bind with high affinity to the C5aR activation
site (Allegretti et al. 2005; Monk et al. 2007). An alter-
native approach to inhibit C5aR activation was inspired by
the discovery of the Chemotaxis Inhibitory Protein of
Staphylococcus aureus abbreviated as CHIPS (Veldkamp
et al. 2000). CHIPS is a 121-residue immune evasive
protein excreted by Staphylococcus aureus bacteria in
order to prevent host inflammatory responses triggered by
formylated peptides and C5a. CHIPS binds to the formy-
lated peptide receptor (FPR) and the C5aR with high
affinity (Kd = 35.4 ± 7.7 nM and Kd = 1.1 ± 0.2 nM,
respectively; Postma et al. 2004). Mutational studies
revealed that the C5aR blocking activity of CHIPS is
entirely conserved in a protein fragment lacking the first 30
residues. This truncated protein was designated CHIPS31–121
and its structure was solved by Haas et al. (2005). CHIPS31–121
has an entirely different folding topology compared to C5a
and is composed of a single a-helix packed onto a four-
stranded anti-parallel b-sheet. This particular topology is
present in several other S. aureus proteins with immune
modulating properties (Haas et al. 2005).
In contrast to C5a, CHIPS binds exclusively to the C5aR
N terminus (Postma et al. 2005). This part of the receptor is
post-translationally modified by introduction of two sulfate
groups on tyrosine residues at positions 11 and 14 (Farzan
et al. 2001). Sulfation of these tyrosines appeared to be
crucial for tight binding to CHIPS31–121 as was concluded
from ITC binding studies using several sulfated and
unsulfated mimics of the C5aR N terminus (Bunschoten
et al. 2009; Ippel et al. 2009). The highest affinity for
CHIPS31–121 (Kd = 8.4 ± 1.1 nM) was observed for a
peptide composed of residues 7–28 of the C5aR with both
tyrosine residues sulfated (designated C5aR7–28S2; Ippel
et al. 2009). This peptide binds almost as strong to CHIPS
as the native C5aR. This implies that all moieties essential
for the interactions between CHIPS and the C5aR are
present within this peptide mimic. The free N terminus of
the C5aR is virtually unstructured, which is also the case
for the short receptor mimics. Upon binding to CHIPS,
residues 10–24 of these C5aR mimics adopt a well-defined
conformation (PDB ID code: 2K3U; Ippel et al. 2009). In
the complex, residues 10–14 and 19–24 of C5aR7–28S2
form two short stretches of b-strand, which are hydrogen
bonded in an anti-parallel fashion to strand b4 and residues
104–107 of CHIPS31–121, respectively. These two stretches
are interconnected by a single turn comprising residues
15–18. Sulfated tyrosine 11 interacts mainly with residues
in the a-helix of CHIPS31–121, while sulfated tyrosine 14 is
primarily accommodated by residues in the loop between
Fig. 1 Topology design of the CHOPS construct. a Cartoon repre-
sentation of one of the NMR structures of CHIPS31–121 (PDB ID code:
1XEE). The two regions interacting with the C5aR are indicated:
residues 43–61 (a-helix and b1) and residues 95–111 (b3 and b4). The
N and C termini as well as the numbering of the b-strands are
indicated. b The amino acid sequence of CHOPS. The D-Pro-Gly
linker is indicated in black. c Cartoon representation of CHOPS based
on the structure of CHIPS31–121. The D-Pro-Gly linker is shown in
stick representation. The numbering of the terminal residues and of
the residues flanking the linker is indicated
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the a-helix and the first b-strand (residues 52–59; Fig. 1a).
The sequence between residues T66 and Y94 of CHIPS31–121
does not contribute to interactions with the receptor, but is
essential for its native structure (Ippel et al. 2009).
Despite its strong C5aR inhibitory potency, intact CHIPS
itself is not amenable for use as an anti-inflammatory agent.
Several immunogenic surface epitopes have been identified
by Gustafsson et al. (2009). A recent study of Wright et al.
(2007) showed the presence of anti-CHIPS antibodies in
numerous serum samples of human donors. Therefore,
administration of intact CHIPS protein can potentially lead
to adverse immunogenic responses. Here, we describe the
design, chemical synthesis, and analysis of a protein con-
struct in which specific segments of CHIPS crucial for
interactions with the C5aR have been incorporated while a
number of non-interacting segments were omitted. We
denote this protein construct with the acronym CHOPS,
which stands for ‘CHemotaxis inhibitory cOnstruct Protein
of Staphylococcus aureus’. The ultimate goal is to obtain a
CHOPS molecule, which is non-immunogenic, but has a
high inhibitory potency for the C5aR.
Materials and methods
Materials
Peptide grade DiPEA, DCM, NMP, TFA, piperidine, and
HPLC grade solvents were purchased from Biosolve B. V.
(Valkenswaard, The Netherlands). Fmoc-protected amino
acids were purchased from GL Biochem Ltd. (Shanghai,
China). Side-chain protecting groups were chosen as: Boc
for lysine, tBu for aspartic acid, glutamic acid, serine,
threonine, and tyrosine, Trt for asparagine and glutamine,
and Pbf for arginine. Unless stated otherwise, chemicals
were obtained from commercial sources and used without
further purification.
Compound analysis
Analytical HPLC was performed using an automatic HPLC
system (Shimadzu) with an analytical reversed-phase col-
umn and a UV detector operating at 214 nm with a flow
rate of 0.75 mL/min. A Phenomenex Gemini C18 column
(110 A˚, 5 lm, 250 9 4.6 mm) was used. TFA buffers
were used (buffer A: H2O:MeOH, 80:20 v:v; buffer B:
H2O:MeOH, 5:95 v:v, both containing 0.1% TFA). Elution
was effected with a linear gradient from 100% A to 100%
B over 48 min. Preparative HPLC was performed using an
automatic Prep LCMS-QP8000a HPLC system (Shimadzu)
with a preparative reversed-phase column and a UV
detector operating at 214 nm with a flow rate of 12.5 mL/
min. A Reprosil-Pur C18-AQ column (120 A˚, 10 lm,
250 9 22 mm) was used. TFA buffers were used (buffer
A: H2O:MeOH, 80:20 v:v; buffer B: H2O:MeOH, 5:95 v:v,
both containing 0.1% TFA). Elution was effected with a linear
gradient from 100% A to 100% B over 100 min. The peptides
were characterized using electrospray mass spectrometry
(ESI-MS), which was performed on a Thermo Finnigan LCQ
DECA XP MAX ion trap mass spectrometer.
Peptide synthesis
CHOPS was synthesized on a Rink Amide PEG resin
(0.52 mmol/g) (Matrix Innovation Inc., Montreal, Canada)
on a 0.25 mmol scale. The peptide was assembled using an
automatic ABI 433A Peptide Synthesizer, equipped with a
UV-monitoring system, which was used to monitor the
Fmoc removal step, i.e., formation of the dibenzofulvene-
piperidine adduct absorbing at 301 nm. ABI FastMoc
0.25 mmol protocols were applied, with the exception of a
standard double coupling of 45 min. The synthesis was
carried out on 0.48 g resin. The resin was washed with
DCM and NMP (five times). Subsequently, 1 mmol of the
appropriate amino acid was dissolved in NMP (2 mL), and
HBTU/HOBt (1 mmol, 2.78 mL of 0.36 M) in NMP was
added. To this mixture, DiPEA (1 mL, 2 M) in NMP was
added, and the activated amino acid was then transferred to
the reaction vessel. After 45 min, the reaction vessel was
drained and the resin was washed with NMP (three times)
followed by addition of another batch of pre-activated
amino acid, which was allowed to couple for another
45 min. Next, any of the remaining free amino groups were
acetylated with an acetic anhydride capping solution
(0.5 M Ac2O, 0.125 M DiPEA, and 0.015 M HOBt in
NMP) for 15 min. After capping the Fmoc protective group
was removed from the N terminus by treatment with 20%
piperidine solution in NMP twice (3 and 7.6 min). The last
coupling cycle was followed by removal of the Fmoc-
group by a 20% piperidine solution, washing the resin with
NMP, and acetylation of the N terminus by treatment with
the acetic anhydride capping solution for 15 min. Finally,
the resin was washed with NMP (five times) and DCM (six
times), removed from the reaction vessel, washed with
ether, and dried in vacuo over P2O5.
The anchored peptide obtained in this way was de-pro-
tected and cleaved from the solid support by treatment with
TFA/H2O/TIS (95/2.5/2.5, 25 mL) for 2 h at room tem-
perature. The mixture was filtered and the residue washed
thoroughly with TFA (two times 10 mL). The reaction
mixture was concentrated in vacuo to a volume of
approximately 10 mL and added dropwise to 90 mL
MTBE/n-hexane (1/1 v/v) solution. The precipitate was
collected by centrifugation (3,000 rpm, 10 min), the
supernatant was decanted and the pellet was resuspended in
MTBE/n-hexane (1/1 v/v) (100 mL) and centrifuged again.
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This procedure was repeated twice. Afterwards, the pellets
were dissolved in CH3CN/water (1/1 v/v) (ca. 60 mL) and
lyophilized to give 595 mg of the crude peptide as a white
fluffy solid.
The crude peptide (400 mg) was dissolved in 30 mL
buffer A, 10 mL buffer B and purified by preparative
HPLC (Reprosil-Pur C18-AQ, TFA buffers) in eight
runs. Pure fractions were pooled and lyophilized to give
29 mg of pure CHOPS. The CHOPS sample was charac-
terized by analytical HPLC (Gemini C18, TFA buffers,
Rt = 36.4 min, Purity [ 98%) (Supplementary Figure 1)
and by ESI-MS (Supplementary Figure 2; calculated
average mass [M ? 5H]5? for C261H422N70O74S: 1,152.34;
found: 1,152.30).
The C5a receptor mimic peptides C5aR7–28 and
C5aR7–28S2 were synthesized as has been described pre-
viously (Bunschoten et al. 2009).
ITC experiments
The binding affinities of the C5aR mimics C5aR7–28 and
C5aR7–28S2 with CHOPS were measured using an ITC200
Microcalorimeter (MicroCal) operating at 283 K. The
measuring cell was filled with 208 lL of a 0.19 mM
solution of CHOPS in a 20 mM sodium phosphate buffer at
pH 6.5. The concentration of CHOPS was determined by
OD280 measurements. The syringe was loaded with 30 lL
of a 2.5 mM solution of one of the C5aR-mimics in the
same buffer system. After each incremental addition of the
solution in the syringe, the integrated heat change due to
binding was measured. The data were analyzed using the
Microcal Origin software and fitted by non-linear regres-
sion analysis. Three independent experiments were carried
out. The experimental errors were estimated by Monte
Carlo simulations using the standard deviations of the
individual experiments.
NMR spectroscopy
NMR samples of C5aR7–28, C5aR7–28S2 and CHOPS were
at concentrations of 0.8–1 mM in 10/90% (v/v) D2O/H2O
sodium phosphate buffers (20 mM, pH 6.5). Spectra were
recorded at 288 K on a Varian INOVA 500 and a Bruker
Avance 750 MHz spectrometer equipped with an HCN
triple-resonance pulsed field gradient probe. Sequential 1H
NMR assignments of CHOPS were accomplished using a
combination of NOESY, TOCSY, and 13C-HSQC spectra.
CD measurements
CD spectra (190–260 nm) were recorded on an Olis
RSM1000 spectrophotometer operating at 2 nm spectral
resolution (slit size 1.24 mm). Samples of CHIPS31–121
(43 lM) in 20 mM sodium phosphate buffer (pH 6.5),
CHOPS (50 lM), C5aR7–28 and C5aR7–28S2 (50 lM) in
10 mM sodium phosphate buffer (pH 7.4) were measured
at 298 K using a 0.5 mm cuvette. To gain a satisfactory
S/N ratio five scans were summed, with data points averaged
by three-point triangular smoothing.
Results and discussion
Design of CHOPS
The Staphylococcal protein CHIPS is one of the most
potent inhibitors of C5a-induced inflammatory responses
presently known. In contrast to the numerous agents
developed to interact directly with the C5aR activation site
located inside the receptor core (Proctor et al. 2006; Chen
et al. 2010), CHIPS blocks activation by C5a by binding
with high affinity to the flexible extra-cellular N-terminal
portion of the C5aR (Postma et al. 2005). The interaction
surface of CHIPS31–121 with the C5aR comprises *20% of
its solvent accessible surface and is not confined to a
limited region of the protein. The interactions between
CHIPS and the C5aR involve a substantial number of non-
sequential amino acids optimally positioned in the inhibi-
tory protein to provide tight binding. A successful mimic of
CHIPS should not only include the amino acid residues (or
mimics of these) crucial for C5aR binding, but also the
amino acids responsible for the proper spatial arrangement
dictated by the CHIPS folding topology. Our first approach
to build such a structure is to leave out a limited number of
residues which do not interact directly with the C5aR, but
with the intention to leave the structural integrity of
CHIPS31–121 intact. NMR titration studies revealed that two
regions of CHIPS31–121 show relatively large perturbations
in the backbone and Cb chemical shifts (Ippel et al. 2009):
the first region includes residues 43–61, which comprises
part of the a-helix and the subsequent loop connecting
strand b1 (Fig. 1a). The second region is composed of
residues 95–111 and comprises strands b3 and b4 of
CHIPS31–121. The non-interacting portion of CHIPS31–121
comprises strand b2 and the long loop connecting b2 with
b3 (Fig. 1a). This portion could potentially be left out by
directly connecting strand b1 with b3 via a tight turn.
Inspection of the NMR structural models of CHIPS31–121
reveals that residue L65 at the end of strand b1 and residue
K95 at the start of strand b3 are proximal and offer an
excellent opportunity to link the two fragments interacting
with the C5aR together to form one short, contiguous
sequence. Several b-hairpin inducing sequences have been
described and reviewed in the literature (Blanco et al.
1998; Stotz and Topp 2004). One of the smallest peptide
fragments, which induces a b-turn and facilitates the
734 A. Bunschoten et al.
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formation of an anti-parallel b-sheet, is the dipeptide
D-Pro-Gly (Haque and Gellman 1997). This fragment was
chosen to link the N- and C-terminal segments of CHIPS,
which interact with the C5aR, together. These segments
were chosen to comprise the complete elements of sec-
ondary structure as present in native CHIPS (i.e. the a-helix
and b-strands b1, b3, and b4) in order to pursue structural
integrity. The resulting construct consisted of the CHIPS
amino acid sequences T36-L65 and K95-G112 intercon-
nected by D-Pro-Gly (Fig. 1b). A number of residues
suggested to be part of discontinuous immunogenic epi-
topes by Gustafsson et al. (2009) are not present in this
construct (designated CHOPS). A model representation of
CHOPS based on the structure of native CHIPS31–121 is
presented in Fig. 1c.
Affinity of CHOPS for the C5aR N terminus
The affinity of the CHOPS fragment for the C5aR was
determined using isothermal titration calorimetry (ITC). We
synthesized two peptide mimics of the C5aR N terminus:
unsulfated peptide C5aR7–28 representing residues 7–28 of
the C5aR and peptide C5aR7–28S2, the same sequence with
tyrosine residues 11 and 14 O-sulfated. We titrated a solution
of CHOPS with these peptides and recorded the subsequent
heat exchange upon formation of the complex. Two typical
ITC experiments are shown in Supplementary Figure 3.
Clearly, titration of the doubly sulfated peptide C5aR7–28S2
to CHOPS resulted in a substantial exothermic effect (Sup-
plementary Figure 3a) while no significant response was
detected in the ITC experiment with the unsulfated peptide
C5aR7–28 (Supplementary Figure 3b). Gratifyingly, the
affinity of CHOPS for C5aR7–28S2 was in the micromolar
range (Kd = 3.6 ± 0.2 lM; n = 3). The complete thermo-
dynamic analysis of these ITC data plus the comparison with
previous ITC studies of CHIPS31–121 and C5a peptide
mimics is compiled in Supplementary Table 1.
NMR spectroscopy
Previous NMR studies revealed that the synthetic peptides
C5aR7–28 and C5aR7–28S2, which mimic the N-terminal
portion of the C5aR, were very flexible in solution and did
not have detectable propensity for any preferred secondary
structure. Although there is no detailed structure available
for the intact C5aR, it is expected that its free extra-cellular
N terminus (residues 1–35) is unstructured as well. The
protein CHIPS31–121 does adopt a well-defined conforma-
tion with flexible regions at the termini and some disorder
in the loop region between the a-helix and strand b1 (Haas
et al. 2005). As could be inferred from 15N relaxation
studies this particular loop region adopts an ordered con-
formation in the complex with C5aR7–28S2 (Ippel et al.
2009). NMR spectra of the free CHOPS construct appear to
be typical for a largely unstructured polypeptide chain
(Supplementary Figure 4a). 2D NOE spectra of free
CHOPS contain predominantly sequential NOEs, but a few
long-range contacts could be identified. These non-
sequential cross-peaks are indicative for an anti-parallel
orientation of strands b1 and b3, which are bridged by the
b-hairpin inducing D-Pro-Gly sequence (Fig. 2).
Titration of CHOPS with the unsulfated receptor mimic
C5aR7–28 did not result in any changes in the
1H-spectrum
of the latter. In contrast, titration of CHOPS with the sul-
fated receptor mimic C5aR7–28S2 resulted in increased
dispersion of resonance lines, which is characteristic for
non-random coil behavior (Supplementary Figure 4b). The
complex between CHOPS and C5aR7–28S2 is still flexible
and the 1H-spectra show a high degree of overlap. Never-
theless, we could assign some of the NMR signals as
indicated in Supplementary Figure 4b. These new signals
are at comparable positions as in spectra of the complex
between CHIPS31–121 and C5aR7–28S2, and indicative for
the formation of native-like structure. Similar features were
observed in 1H–13C HSQC spectra upon titration of
C5aR7–28S2 to CHOPS (Fig. 3).
The NOESY spectra of the CHOPS:C5aR7–28S2 com-
plex suffer from severe overlap, but still a limited number
of long-range intra-molecular and inter-molecular NOE
cross-peaks could be assigned. Inter-molecular NOEs were
identified between the aromatic side-chain protons of sul-
fated tyrosine sY14 of C5aR7–28S2 and the side-chains of
T53 (Fig. 4a) and Y108 (Fig. 4c) of CHOPS. H13 of
C5aR7–28S2 has an NOE contact with V109 of CHOPS
(Fig. 4b). Intra-molecular NOEs were identified between
T53 and L49 and between Y97 and V109 (Fig. 4a). Similar
peaks were observed in NOESY spectra of the complex
between CHIPS31–121 and C5aR7–28S2. The position of
these residues in the NMR structure of the CHIPS31–121:
C5aR7–28S2 complex is indicated in Fig. 4d, e.
CD spectroscopy
The presence of residual structure in the C5aR mimics and
CHOPS was also monitored by CD spectroscopy. The CD
spectra of the C5a-receptor mimics C5aR7–28 and
C5aR7–28S2, and CHOPS show no structural features apart
from a shallow minimum at 200 nm (Fig. 5). The CD
spectrum of free CHIPS31–121 comprises a large positive
signal around 190 nm and a minimum around 205 nm
(Fig. 5). This spectrum does not change significantly upon
binding of C5aR7–28S2 (data not shown). Titration of
CHOPS with a stoichiometric amount of unsulfated
receptor mimic C5aR7–28 resulted in an increase of the CD
signal, although the shape of the spectrum did not change
(Fig. 5a). Stoichiometric titration of CHOPS with sulfated
A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus 735
123
receptor mimic C5aR7–28S2, on the other hand yielded a
clear change of the CD spectrum: an increase in the signal
around 190 nm and a shift of the minimum from 200 to
205 nm (Fig. 5b). These changes shift the appearance of
the CD spectrum towards that of CHIPS31–121 although at
lower intensities.
In this study we aimed to create a shorter version of the
immune evasive protein CHIPS based on the NMR struc-
ture of the complex between CHIPS31–121 and C5aR7–28S2.
The construct we designed (CHOPS) comprises all portions
of CHIPS31–121 important in the interaction with the C5aR.
Portions outside the binding region including strand b2 and
the connecting loop between b2 and b3 were discarded.
This was accomplished by coupling strand b1 and b3
together via a D-Pro-Gly linker segment. The resulting
50-residue long peptide appeared to be largely unfolded
apart from some residual structure around the b-hairpin
inducing D-Pro-Gly linker sequence. ITC studies revealed
that CHOPS binds to the doubly sulfated C5a-receptor
mimic C5aR7–28S2 with micromolar affinity (Kd = 3.6 ±
0.2 lM). Although the affinity of C5aR7–28S2 to CHOPS is
three orders of magnitude lower compared to binding to
CHIPS31–121 (Kd = 8.4 ± 1.2 nM; Ippel et al. 2009), this
is a very promising result for a first lead compound. No
detectable affinity of CHOPS was observed in the ITC
measurements using the unsulfated mimic C5aR7–28. This
is consistent with previous measurements of CHIPS31–121
and C5aR7–28, which revealed that the absence of the two
sulfate moieties results in an almost 400-fold decrease in
affinity.
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NMR spectroscopy confirmed the results obtained by
ITC. Titration of CHOPS with unsulfated receptor mimic
C5aR7–28 resulted in the sum of its constituent
1H-spectra,
while titration of doubly sulfated peptide C5aR7–28S2
yielded a completely different 1H-spectrum with signals
shifted from their random coil position. The latter is
indicative for the formation of defined structural ele-
ments. The NMR titration experiments using C5aR7–28S2
showed binding in a fast-exchange regime, compatible
with the observed micromolar affinity by ITC (Cavanagh
et al. 2007). Several characteristic features observed in
spectra of the CHIPS31–121:C5aR7–28S2 complex were
also present in spectra of CHOPS:C5aR7–28S2. Specific
resonances of residues L49, T53, T96, Y97, Y108, V109
and N111 have chemical shifts comparable with their
counterparts in the CHIPS31–121:C5aR7–28S2 complex. We
also observed NOE cross-peaks between residues sY14,
T53, L49, and Y108 and between residues H13, V109,
and Y97 in NOESY spectra of CHOPS:C5aR7–28S2.
These peaks are reminiscent of NOE contacts observed
in spectra of the complex between CHIPS31–121 and
C5aR7–28S2 and reveal that CHOPS, in the presence of
sulfated peptide C5aR7–28S2, adopts similar structures as
native CHIPS31–121.
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The structural characteristics of CHOPS, either free in
solution or in complex with the C5aR mimics, were also
studied by CD spectroscopy. The spectra of the separate
peptides (CHOPS, C5aR7–28 or C5aR7–28S2) did not show
any significant absorption apart from a shallow minimum
around 200 nm. Titration of CHOPS with receptor mimic
C5aR7–28 increased the amount of absorption, but not the
position of its minimum. Titration of CHOPS with the
doubly sulfated receptor mimic C5aR7–28S2 caused an
increase in absorption around 190 nm as well as a shift of
the absorption minimum from 200 to 205 nm. Although the
maximum and minimum intensities are smaller, the overall
shape of the CD spectrum of the CHOPS:C5aR7–28S2
complex resembles that of native CHIPS31–121.
Conclusions
We have designed and synthesized a significantly reduced-
size mimic of the protein CHIPS, which we coined
CHOPS. This construct has a binding affinity of 3.6 lM
with respect to the sulfated receptor mimic C5aR7–28S2, but
no affinity for the unsulfated receptor mimic C5aR7–28. We
conclude, based on NMR and CD studies, that CHOPS
adopts structures comparable with native CHIPS31–121
upon binding of C5aR7–28S2. The CHOPS:C5aR7–28S2
complex is, however, still flexible. We expect that
improved affinity can be achieved by introduction of more
rigid moieties, which will force this mimic more into the
structure of native CHIPS.
0.4
0.2
0.0
-0.2
-0.4
1H/ppm
7.4 7.2 7.0 6.8 6.6
δ
6.0
5.9
5.8
5.7
5.6
8.8 8.6 8.4 8.2 8.0
7.8 7.6 7.4 7.2
0.4
0.2
0.0
-0.2
-0.4
1H/ppm
δ
1H/ppm
δ
(a)
(b)
(c)
(d)
(e)
Fig. 4 Observed cross-peaks in the NOESY spectrum of the
CHOPS:C5aR7–28S2 complex in relation to structural features of the
CHIPS31–121:C5aR7–28S2 complex (PDB ID code: 2K3U). a–c Differ-
ent sections of the NOESY spectrum recorded at 288 K of a 1:1
mixture of CHOPS and C5aR7–28S2. Identified long-range intra-
molecular and inter-molecular NOE cross-peaks are indicated
(normal fonts for residues belonging to CHOPS and italic fonts for
residues belonging to C5aR7–28S2). d–e Cartoon representation of the
structure of the CHIPS31–121:C5aR7–28S2 complex. The side-chains of
the residues identified in a–c are shown in stick representation. NOE
cross-peaks observed in a–c are indicated by arrows in the structure
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Fig. 5 Circular dichroism spectra (CD) of CHOPS, CHIPS31–121 and
C5aR mimics. a CD spectra of CHOPS, C5aR7–28, CHOPS:C5aR7–28,
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C5aR7–28S2, and CHIPS31–121
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